A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.

Mills H, Acquah R, Tang N, Cheung L, Klenk S, Glassen R, Pirson M, Albert A, Hoang DT, Van TN

Open source

DOI
10.1155/2022/7702512
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/7702512,
  title = {A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.},
  author = {Mills H and Acquah R and Tang N and Cheung L and Klenk S and Glassen R and Pirson M and Albert A and Hoang DT and Van TN},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/7702512},
  url = {https://doi.org/10.1155/2022/7702512}
}

RIS

TY  - JOUR
TI  - A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.
AU  - Mills H
AU  - Acquah R
AU  - Tang N
AU  - Cheung L
AU  - Klenk S
AU  - Glassen R
AU  - Pirson M
AU  - Albert A
AU  - Hoang DT
AU  - Van TN
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/7702512
UR  - https://doi.org/10.1155/2022/7702512
ER  - 

APA

H, M., R, A., N, T., L, C., S, K., R, G., M, P., A, A., DT, H., & TN, V. (2022). A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/7702512

Source records